These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15164610)

  • 1. [Neuropsychopharmacological profile of nicotine].
    Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):55-9. PubMed ID: 15164610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats.
    Franke RM; Park M; Belluzzi JD; Leslie FM
    Eur J Neurosci; 2008 Jun; 27(11):2952-61. PubMed ID: 18588535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
    Markou A; Paterson NE; Semenova S
    Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice.
    Blokhina EA; Kashkin VA; Zvartau EE; Danysz W; Bespalov AY
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):219-25. PubMed ID: 15695068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.
    David V; Besson M; Changeux JP; Granon S; Cazala P
    Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 receptor antagonists for the treatment of nicotine addiction.
    Cohen C; Kodas E; Griebel G
    Pharmacol Biochem Behav; 2005 Jun; 81(2):387-95. PubMed ID: 15935455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys.
    Goldberg SR; Spealman RD
    Fed Proc; 1982 Feb; 41(2):216-20. PubMed ID: 7060749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous self-administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus.
    Alderson HL; Latimer MP; Winn P
    Eur J Neurosci; 2006 Apr; 23(8):2169-75. PubMed ID: 16630063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists.
    Sorge RE; Clarke PB
    J Pharmacol Exp Ther; 2009 Aug; 330(2):633-40. PubMed ID: 19448141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
    Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L
    Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
    Pogocki D; Ruman T; Danilczuk M; Danilczuk M; Celuch M; Wałajtys-Rode E
    Eur J Pharmacol; 2007 Jun; 563(1-3):18-39. PubMed ID: 17376429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug self-administration methods to the study of drug craving (drug seeking behavior)].
    Nawata Y; Yamamoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):158-65. PubMed ID: 18646641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of the dorsomedial frontal cortex block sensitization to the positive-reinforcing effects of cocaine.
    Smith MA; Ward SJ; Roberts DC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):238-46. PubMed ID: 17904623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.